ArticleBMC cancer2023

Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study.

Jian Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.